Form 4: Mural Oncology Chief Medical Officer Vicki L. Goodman Reports Share Sale
SEC Filing
Vicki L. Goodman, Chief Medical Officer of Mural Oncology plc, reports the sale of 13,186 ordinary shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Vicki L. Goodman, the Chief Medical Officer of Mural Oncology plc, filed a Form 4 with the SEC.
- The form reports a transaction that occurred on February 24, 2025, where 13,186 ordinary shares were sold at a price of $3.89 per share.
- The sale was executed automatically under a pre-existing Rule 10b5-1 trading plan established on October 24, 2024.
- Following the transaction, Goodman beneficially owns 54,763 ordinary shares, which includes 54,763 unvested restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider share sale under a pre-arranged trading plan, suggesting a neutral sentiment.
Industry Context
Sales by insiders are a normal part of corporate activity. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on current inside information.
Stakeholder Impact
- The sale of shares by a company officer could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| October 24, 2024 | Date the Rule 10b5-1 trading arrangement was entered into. |
| February 24, 2025 | Date of the share sale transaction. |
| February 25, 2025 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.